Viewing Study NCT03356769

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:50 PM
Ignite Modification Date: 2026-06-14 @ 3:45 AM
Study NCT ID: NCT03356769
Status: UNKNOWN
Last Update Posted: 2020-06-09
First Post: 2017-11-02
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex
Sponsor: Peking Union Medical College Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Tuberous Sclerosis Complex View
None Aspirin View
None Epilepsy View
None Cognitive Decline View
None Skin Lesions View
Keywords:

Keywords

Keyword Brief Keyword Text View
None refractory seizure View
None cognitive impairment View
None electroencephalography improvement View
None seizure reduction View
None seizure free View
None aspirin View